Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Genentech Inc.
Current Parent Company:
Roche
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $33,500,000
Year: 2016
Date: June 6, 2016
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: drug or medical equipment safety violation
Mega-Scandal:
Pharmaceutical Hazards
Violation Description: Pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC agreed to pay $67 million to resolve False Claims Act allegations that they made misleading statements about the effectiveness of the drug Tarceva to treat non-small cell lung cancer. The announcement did not indicate how much each company would pay. Here we assume the total was split evenly between them.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: Switzerland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Archived Source:
(click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
